Evidence map›Paper›PMID 32872366›Full record

ReviewMedicina (Kaunas, Lithuania)2020

Asthma: New Integrative Treatment Strategies for the Next Decades.

Diego A Arteaga-Badillo, Jacqueline Portillo-Reyes, Nancy Vargas-Mendoza, José A Morales-González, Jeannett A Izquierdo-Vega, Manuel Sánchez-Gutiérrez, Isela Álvarez-González, Ángel Morales-González, Eduardo Madrigal-Bujaidar, Eduardo Madrigal-Santillán

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Serum autophagy protein 5 is positively related to T helper 2/T helper 1 ratio, inflammation, and exacerbation in adult asthma patients.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Diego A Arteaga-BadilloInstituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla, Pachuca de Soto 42080, Mexico.
Jacqueline Portillo-ReyesInstituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla, Pachuca de Soto 42080, Mexico.
Nancy Vargas-MendozaEscuela Superior de Medicina, Instituto Politécnico Nacional, "Unidad Casco de Santo Tomas", Ciudad de México 11340, Mexico.ORCID 0000-0002-2528-5538
José A Morales-GonzálezEscuela Superior de Medicina, Instituto Politécnico Nacional, "Unidad Casco de Santo Tomas", Ciudad de México 11340, Mexico.ORCID 0000-0002-5980-0980
Jeannett A Izquierdo-VegaInstituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla, Pachuca de Soto 42080, Mexico.
Manuel Sánchez-GutiérrezInstituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla, Pachuca de Soto 42080, Mexico.ORCID 0000-0003-0342-8080
Isela Álvarez-GonzálezEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, "Unidad Profesional A. López Mateos", Ciudad de México 07738, Mexico.ORCID 0000-0003-4011-9121
Ángel Morales-GonzálezEscuela Superior de Cómputo, Instituto Politécnico Nacional, "Unidad Profesional A. López Mateos", Ciudad de México 07738, Mexico.ORCID 0000-0003-2920-8078
Eduardo Madrigal-BujaidarEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, "Unidad Profesional A. López Mateos", Ciudad de México 07738, Mexico.
Eduardo Madrigal-SantillánEscuela Superior de Medicina, Instituto Politécnico Nacional, "Unidad Casco de Santo Tomas", Ciudad de México 11340, Mexico.ORCID 0000-0003-2264-4598
Instituto Politécnico Nacional · MXUniversidad Autónoma del Estado de Hidalgo · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic disease whose main anatomical-functional alterations are grouped into obstruction, nonspecific bronchial hyperreactivity, inflammation and airway remodeling. Currently, the Global Initiative of Asthma 2020 (GINA 2020) suggests classifying it into intermittent cases, slightly persistent, moderately persistent and severely persistent, thus determining the correct guidelines for its therapy. In general, the drugs used for its management are divided into two groups, those with a potential bronchodilator and the controlling agents of inflammation. However, asthmatic treatments continue to evolve, and notable advances have been made possible in biological therapy with monoclonal antibodies and in the relationship between this disease and oxidative stress. This opens a new path to dietary and herbal strategies and the use of antioxidants as a possible therapy that supports conventional pharmacological treatments and reduces their doses and/or adverse effects. This review compiles information from different published research on risk factors, pathophysiology, classification, diagnosis and the main treatments; likewise, it synthesizes the current evidence of herbal medicine for its control. Studies on integrative medicine (IM) therapies for asthmatic control are critically reviewed. An integrative approach to the prevention and management of asthma warrants consideration in clinical practice. The intention is to encourage health professionals and scientists to expand the horizons of basic and clinical research (preclinical, clinical and integrative medicine) on asthma control.

Indexed as

Antibodies, MonoclonalAnti-Inflammatory AgentsAntioxidantsAsthmaBronchodilator AgentsHumansOxidative StressPlant PreparationsRisk FactorsAntibodies, MonoclonalAnti-Inflammatory AgentsAntioxidantsBronchodilator AgentsPlant Preparationsantioxidantsasthmadiagnosisoxidative stresstreatment strategies

Identifiers

PMID32872366
PMCPMC7558718
OpenAlexW3082792606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.